Skip to main content

MediWound Ltd.

corporate_fare Company Profile

MediWound Ltd.

MDWD·NASDAQ·Life Sciences·CIK 0001593984

MediWound Ltd. is a biopharmaceutical company that develops, manufactures, and sells new biological and non-surgical treatments for tissue repair and regeneration. The company operates in the United States, Germany, Italy, Spain, and other international markets. MediWound's primary commercial product is NexoBrid, a biopharmaceutical used to remove dead tissue (eschar) from patients with deep partial- and full-thickness thermal burns. This product is sold to burn centers and hospital burn units. The company is also developing EscharEx, an enzymatic therapy based on bromelain, intended for treating chronic and other difficult-to-heal wounds. Additionally, MediWound is developing MW005, a biological product candidate applied topically to treat non-melanoma skin cancers. MediWound Ltd. was founded in 2000 and has its headquarters in Yavne, Israel.

MediWound Ltd. (NASDAQ:MDWD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 19 items for MDWD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for MDWD spans 6-K, 424B5, 20-F.

Recent high-impact activity:

  • MediWound Posts 65-Cent Quarterly Loss Per Share
  • MediWound's $12.50 Bought Deal Grows to $17.25M as Wainwright Exercises Full Option
  • MediWound Prices $15M Bought Deal at $12.50, a Premium to the $11.78 Close
  • MediWound Launches Underwritten Share Offering With H.C. Wainwright; Terms Unpriced
  • MediWound Secures $3.3M U.S. Funding for Room-Temp NexoBrid

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$16.96M
Net Income
-$23.88M
Diluted EPS
-$2.10
Op. Cash Flow
-$16.12M
Free Cash Flow
-$21.63M
Gross Profit
$3.25M
Operating Income
-$25.27M
Cash & Equivalents
$4.8M
Debt / Equity
0.00×
Net Margin
-140.8%
Shares Outstanding
12.84M sh
Source: 20-F · filed 2026-03-05 · accession 0001178913-26-000749

Short Interest & Short Volume

14.73 days to cover

FINRA reported short interest of 1,790,576 shares in MDWD as of the October 30, 2026 settlement, a 2.3% increase from the prior period — about 14.7 days to cover at its recent average daily volume. On November 20, 2026, 58.6% of MDWD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,790,576 shares as of October 30, 2026
Change vs prior period▲ 2.3%
Days to cover14.73 at avg daily volume of 121,580
Daily short volume (FINRA facilities)58.6% of 70,472 shares on November 20, 2026
5-day average short volume53.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for MDWD, detected from its recent SEC filings · based on capital-structure filings through 2026-11-05.

1 recent capital raise

Bought Deal Terms Confirmed · Net Proceeds and Fees

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

MDWD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with M →
$13.59
52-week range · as of 2026-11-05 $11.8 – $19.7
Market cap
$175.45M
Volume
187.8K (1.2× avg)
3-mo avg 153.7K
Live data · 2026-11-22 12:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MDWD - Latest Insights

MDWD
Nov 12, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.82
Real-time Price: $13.59 info
Change: -$0.230 (-2%) info
Market Cap: $175.451M info
MDWD
Nov 05, 2026, 11:27 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $13.30
Real-time Price: $13.59 info
Change: +$0.295 (+2%) info
Market Cap: $175.451M info
MDWD
Nov 03, 2026, 4:40 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.78
Real-time Price: $13.59 info
Change: +$1.81 (+15%) info
Market Cap: $175.451M info
MDWD
Nov 03, 2026, 4:39 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $13.39
Real-time Price: $13.59 info
Change: +$0.200 (+1%) info
Market Cap: $175.451M info
MDWD
Sep 22, 2026, 8:09 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.31
Real-time Price: $13.59 info
Change: +$0.280 (+2%) info
Market Cap: $175.451M info
MDWD
Aug 25, 2026, 8:00 AM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $13.28
Real-time Price: $13.59 info
Change: +$0.310 (+2%) info
Market Cap: $175.451M info
MDWD
Aug 13, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $13.91
Real-time Price: $13.59 info
Change: -$0.320 (-2%) info
Market Cap: $175.451M info
MDWD
Aug 13, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.91
Real-time Price: $13.59 info
Change: -$0.320 (-2%) info
Market Cap: $175.451M info
MDWD
May 28, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $14.33
Real-time Price: $13.59 info
Change: -$0.740 (-5%) info
Market Cap: $175.451M info
MDWD
May 27, 2026, 7:08 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $16.68
Real-time Price: $13.59 info
Change: -$3.09 (-19%) info
Market Cap: $175.451M info
MDWD
May 27, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $16.68
Real-time Price: $13.59 info
Change: -$3.09 (-19%) info
Market Cap: $175.451M info
MDWD
May 25, 2026, 8:32 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $16.58
Real-time Price: $13.59 info
Change: -$2.99 (-18%) info
Market Cap: $175.451M info
MDWD
Apr 02, 2026, 3:26 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $16.92
Real-time Price: $13.59 info
Change: -$3.33 (-20%) info
Market Cap: $175.451M info
MDWD
Mar 05, 2026, 7:30 AM EST
Filing Type: 20-F
Importance Score:
8
Price at Filing: $17.20
Real-time Price: $13.59 info
Change: -$3.61 (-21%) info
Market Cap: $175.451M info
MDWD
Mar 05, 2026, 7:07 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $17.20
Real-time Price: $13.59 info
Change: -$3.61 (-21%) info
Market Cap: $175.451M info
MDWD
Mar 05, 2026, 7:05 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $17.20
Real-time Price: $13.59 info
Change: -$3.61 (-21%) info
Market Cap: $175.451M info
MDWD
Feb 19, 2026, 4:05 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $17.27
Real-time Price: $13.59 info
Change: -$3.68 (-21%) info
Market Cap: $175.451M info
MDWD
Jan 15, 2026, 4:05 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $17.37
Real-time Price: $13.59 info
Change: -$3.78 (-22%) info
Market Cap: $175.451M info
MDWD
Jan 12, 2026, 7:08 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $19.30
Real-time Price: $13.59 info
Change: -$5.71 (-30%) info
Market Cap: $175.451M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets